WuXi Biologics (Cayman) Inc.
WXXWY | OTC
$13.45
-$0.33 (-2.39%)
At close: Sep 22, 2026, 3:59 PM ET
$13.53
+$0.08 (+0.59%)
After-hours:
Sep 22, 2026, 3:33 PM ET
Market Data
Market Cap $28.29B
Enterprise Value $196.17B
Beta 0.60
Average Volume N/A
Shares Outstanding (Diluted) 2.09B
Shares Change YoY -3.77%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M 14.6%
Price Change 3M 72.0%
Price Change 6M 63.5%
Price Change YTD 65.0%
Price Change 1Y 33.9%
Price Change 3Y 26.8%
Price Change 5Y -54.1%
1M CAGR (ann.) 18.2%
1Y CAGR (ann.) 37.8%
5Y CAGR (ann.) -14.1%
All-Time CAGR 32.4%
Valuation
PE Ratio 50.72
Forward PE 24.70
PEG Ratio 1.87
Forward PEG 1.53
PS Ratio 10.18
Forward PS 5.90
PB Ratio 4.51
P/FCF Ratio 110.16
P/Adj. FCF Ratio 237.73
P/OCF Ratio 88.77
EV/Sales 9.78
EV/EBIT 33.27
EV/EBITDA 26.83
EV/FCF 105.87
Earnings Yield 2.1%
FCF Yield 1.0%
Adj. FCF Yield 0.5%
Financial Health
Net Cash ¥8.86B
Total Debt ¥5.11B
Cash & Short-Term Investments ¥12.54B
Total Assets ¥60.44B
Current Ratio 3.04
Quick Ratio 2.82
Debt / Equity Ratio 0.06
Debt / EBITDA 0.70
Debt / FCF 2.76
OCF / Debt 0.77
Interest Coverage 74.60
Altman Z-Score 11.68
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 47.5%
Operating Profit Margin 29.3%
EBITDA Margin 37.4%
Net Profit Margin 21.2%
FCF Margin 9.2%
Adj. FCF Margin 4.3%
SBC / Revenue 1.9%
SBC Impact (per share) -53.7%
Returns
Return on Assets 7.7%
Return on Equity 10.5%
Return on Invested Capital 10.6%
Return on Capital Employed 13.4%
Return on Tangible Assets 8.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 86.6%
Revenue CAGR 5Y 114.2%
Revenue CAGR 10Y 49.6%
EPS CAGR 3Y 67.1%
EPS CAGR 5Y 150.7%
EPS CAGR 10Y 51.4%
FCF CAGR 3Y 518.3%
FCF CAGR 5Y 103.4%
FCF CAGR 10Y 6.1%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y 37.2%
Revenue Growth Next 3Y 28.4%
Earnings Date Mar 22, 2027
EPS Estimate (next Q) $0.03
EPS Growth Est (next Q) 19.5%
Revenue Est (next Q) $305.92M
Revenue Growth Est (next Q) 23.4%
Fair Value Estimates
Graham Number $3.38
Graham Upside -75.5%
Lynch Fair Value $6.79
Lynch Upside -50.7%
Price Target N/A
Price Target Upside N/A
Cash Flow
Operating Cash Flow ¥3.92B
Free Cash Flow ¥1.85B
Adj. Free Cash Flow ¥858.6M
FCF Per Share $0.68
OCF Per Share $1.12
OCF/S Ratio 19.5%
Income Statement
Revenue ¥20.05B
Gross Profit ¥8.55B
Operating Income ¥5.88B
EBITDA ¥7.31B
Net Income ¥4.2B
EPS (Diluted) $1.96
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove WXXWY